Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.
| 17-alpha-Estradiol | Arimistane | |
|---|---|---|
| Category | Hormones | Hormones |
| Standard Dose | — | — |
| Timing | — | — |
| Cycle Duration | — | — |
| Evidence Level | Preclinical | Low |
Non-feminizing estrogen that extends lifespan in male mice via metabolic improvements. Reduces hepatic mTOR signaling, improves glucose homeostasis, and reduces inflammation without estrogenic effects on reproductive tissues.
Suicidal aromatase-modulating compound marketed to reduce estrogen conversion, though evidence quality and product purity vary.
Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.
Get Your Free Protocol →or take the assessment →